Blog

RSS Feed
Posted by Michael Wonder on 08 Nov 2021

SMC - November 2021 decisions

8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published ...

Read more →
Posted by Michael Wonder on 20 May 2021

NICE turns down Janssen's Erleada

20 May 2021 - NICE has published draft guidance rejecting Janssen's Erleada (apalutamide) with androgen deprivation therapy for treating prostate ...

Read more →
Posted by Michael Wonder on 08 Jun 2020

NICE publishes appraisal consultation for isatuximab in combination with pomalidomide and dexamethasone for treating patients with relapsed and refractory multiple myeloma

 4 June 2020 - The appraisal committee has considered the evidence submitted by the company and the views of non-company consultees ...

Read more →